Clinical Trial Update: A Phase II Multi-center Pilot Study of Concurrent Temozolomide and Whole Brain Irradiation in Lung Cancer and Breast Cancer Patients With Brain Metastases [Phase 2]

View source ↗

Summary

Phase II multi-center pilot trial evaluating concurrent temozolomide with whole-brain irradiation in patients with brain metastases from lung or breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Lung Cancer and Breast Cancer Patients With Brain Metastases | Phase 2 | Status: UNKNOWN